Lars Sjöström et al N Engl J Med 2004; 351: 2683- 93 Characteristics of the Subjects at the Time of Matching and at the Time of the Inclusion Examination.

Slides:

Advertisements

Similar presentations

Prevalence of Obesity* among U.S. Adults BRFSS, 2000 Source: Mokdad A H, et al. J Am Med Assoc 2000;284:13 No Data

Advertisements

Surgical Intervention Including Devices Victor F Garcia MD.

Time line of data collection in the Nurses’ Health Study, 1988 to 2000 A. Heather Eliassen et al, Arch Intern Med. 2005; 165:

Nonsense Mutations in PCSK9 and Cardiovascular Risk Factors among 3363 Black Participants in the Study Jonathan C.Cohen, et al, N Engl J Med 2006;354:

1 Background Hypertension Type 2 diabetes Coronary heart disease Gallbladder disease Certain cancers Dyslipidemia Stroke Osteoarthritis Sleep apnea Approximately.

HEALTHY EATING And LIVING Kenneth E. Nixon MD. Problem Overweight and Obesity 97 million adults are overweight or obese Medical Problems Associated with.

Minimally Invasive Surgery Symposium Modest Weight Loss in T2 DM: Lessons from the Look AHEAD Trial Donna H. Ryan, MD Pennington Biomedical Research Center.

Frank B. Hu et al N Engl J Med 2004; 351: Body-Mass Index and Relative Risk of Death from All Causes during 24 Years of Follow-up.

Medical Management of obesity Perinatal ANGELS Conference Feb 17, 2005 Philip A. Kern.

The TRial Of Preventing HYpertension (TROPHY) TROPHY.

Type 2 Diabetes – A Global Epidemic Arya M Sharma, MD, FRCP(C) Professor of Medicine Research Chair for Obesity Research & Management University of Alberta.

Pai JK et al. N Engl J Med 2004; 351: Relative CHD risk by increasing baseline CRP plasma levels,* relative to CRP

Demographic Characteristics of the Study Population - Part I Jenny N.Poynter et al N Engl J Med 2005;352:

Solomon Tesfaye et al N Engl J Med 2005;352: Comparison of Baseline Data in 1819 Patients According to Whether There Was an Assessment for Neuropathy.

FACTORS THAT INCREASE YOUR RISK OF DEVELOPING HIGH BLOOD PRESSURE: Family history of high blood pressure Race (African-Americans are more likely to.

Diabetes Prevention Program (DPP)

1 The Costs of Diabetes in Europe Don’t Lose Sight of the Costs Rhys Williams Prifysgol Cymru Abertawe (University of Wales Swansea, UK)

Evaluation of Current Eligibility Criteria for Bariatric Surgery Diabetes prevention and risk factor changes in the Swedish Obese Subjects (SOS) study.

Contributions to Type 2 Diabetes. Glucose in balance meal Time in minutes Blood glucose levels, mg/dL Insulin levels, uU/mL Glucagon.

Baseline Characteristics of 1994 of Men With Incident CHD (1994 to 2000) and Matched Control Subjects From the Health Professionals Follow-up Study T.

An American Epidemic. Age-adjusted Percentage of U.S. Adults Who Were Obese or Who Had Diagnosed Diabetes Obesity (BMI ≥30 kg/m 2 ) Diabetes

Flowchart of study participants MedDiet indicates Mediterranean diet; VOO, virgin olive oil Jordi Salas-Salvado, et al. Arch Intern Med 2008;168:

Characteristics of studies on lifestyle interventions included in review Gillies CL, et al. BMJ 2007;334:

Structure of Cis and Trans Fatty Acids

Baseline Mean Daily Servings of Coffee and Other Beverages and of Caffeine in Women in the Iowa Women’s Health Study, 1986* *Data are given as.

Hypertension Was the Major Risk Factor Leading to Development of Cardiovascular Diseases Among Men with Hyperuricemia 國立臺北護理健康大學護理所 Kuan-Chia Lin 林寬佳,

RESULTS OF THE RIMONABANT IN OBESITY (RIO) PROGRAM AT 1 YEAR

Baseline Demographic and Clinic Variables According to Office vs 24-Hour or Home BP Giuseppe Mancia, et al. Hypertension 2006;47;

Baseline Characteristics of the Patients Part I

Obesity Trends* Among U.S. Adults BRFSS, 1985

Baseline Characteristics of Women and Men in Whom Coronary Heart Disease Developed during Follow-up and Matched Controls - A Jennifer K. Pai et al. N.

Change (with 95% CI) in outcomes by duration of type 2 diabetes

Nat. Rev. Nephrol. doi: /nrneph

Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Cardiol. doi: /nrcardio

Placebo group 5-mg rimonabant group p 20-mg rimonabant group

Relative risk of hypertension by quintiles of lipids (mg/dL)

Description of studies for pooled analyses

Risk of major congenital malformations among study infants according to fetal exposure to antihypertensives during first trimester alone* Variable ACE.

(p for noninferiority < 0.001)

Relative risk reduction for incident hypertension associated with weight loss of 6.8 kg: The Framingham Study Cohort Risk reduction (%) Relative risk.

Risk for BMI outcome (%)

Baseline Characteristics of 400 Women Who Subsequently Developed Incident Hypertension (Case Subjects) and 400 Women Who Remained Free of Hypertension.

Enrollment and Outcomes

Inclusion Criteria for Patients with Multiple Atherothrombotic Risk Factors and for Those with Established Cardiovascular Disease Deepak L.Bhatt, et al,

Baseline Characteristics of the Subjects

Baseline Characteristics According to Sex

A.V. Khera et al. N Engl J Med 2011;364:127-35

Baseline Characteristics of the Study Participants

Age-standardized probability of finding undiagnosed diabetes among the US population without diagnosed diabetes aged ≥18 years by survey cycle. Age-standardized.

Baseline Characteristics of the Subjects*

Baseline characteristics for patients with diabetes in ASCOT-LLA Part I P.S. SEVER et al Diabetes Care 2005; 28: 1151–1157.

Effects of Pay-for-Performance on the Quality of Primary Care in England Mean Scores for Clinical Quality at the Practice Level for Aspects of Care for.

Baseline Characteristics

Baseline Demographic Characteristics of Adults With Diagnosed Heart Failure and Eligible to Receive Lipid-Lowering Therapy Alan S. Go, et al.

Age-Standardized Rates of Death from Any Cause According to the Estimated GFR among 1,120,295 Ambulatory Adults Alan S.Go et al. N Engl J Med 2004; 351:

Characteristics of Participants in the Nurses Health Study According to Alcohol Intake Meir J.Stampfer et al N Engl J Med 2005;352:

Enrollment and Retention

Change in (A) total cholesterol; (B) LDL-cholesterol; (C) HDL-cholesterol and (D) triglycerides over 5 years in response to 12-week intensive lifestyle.

Baseline Characteristics of Elderly Participants in the Cardiovascular Health Study,According to Quintiles of Cystatin C Michael G.Shlipak et al N Engl.

Baseline Lipid Parameters and Characteristics Among 3110 Men According to Quintiles of Total Cholesterol Ruben O. Halperin et al, Hypertension 2006;47;45-50.

Demographic and Clinical Characteristics (means ± SD or %) of Subjects in Different Office SBP and DBP Categories Mancia G et al Hypertension. 2005;45:1072.

Change in %A1C over 5 years in response to 12-week intensive lifestyle intervention used in a real-world clinical practice. Change in %A1C over 5 years.

Baseline characteristics of older women (NHS I), younger women (NHS II), and men (HPFS) with a history of hypertension according to thiazide use Eric N.

RECORD Study: Enrollment and Outcomes

Change in (A) systolic blood pressure and (B) diastolic blood pressure over 5 years in response to 12-week intensive lifestyle intervention in a real-world.

A Single Participant Exposed Twice to an Inflammatory Stimulus

Percentage of weight loss over 5 years in response to 12-week intensive lifestyle intervention in a real-world clinical practice. Percentage of weight.

Fig. 1: Relative risks of death from any cause among participants with various risk factors (e.g., history of hypertension, chronic obstructive pulmonary.

ATP III Guidelines Benefit Beyond LDL-Lowering:

Presentation transcript:

Lars Sjöström et al N Engl J Med 2004; 351: Characteristics of the Subjects at the Time of Matching and at the Time of the Inclusion Examination of the Intervention Study

Lars Sjöström et al N Engl J Med 2004; 351: Weight Changes among Subjects in the SOS Study over a 10-Year Period

Lars Sjöström et al N Engl J Med 2004; 351: Percentage Changes in Weight, Anthropometric Variables, Risk Factors, and Energy Intake at 2 and 10 Years

Lars Sjöström et al N Engl J Med 2004; 351: Lifestyle Changes among the Subjects in the SOS Study over a 10-Year Period * P<0.01 † P<0.05

Lars Sjöström et al N Engl J Med 2004; 351: Lifestyle Changes among the Subjects in the SOS Study over a 10-Year Period * P<0.01 † P<0.05

Lars Sjöström et al N Engl J Med 2004; 351: Lifestyle Changes among the Subjects in the SOS Study over a 10-Year Period * P<0.01 † P<0.05

Lars Sjöström et al N Engl J Med 2004; 351: Incidence of Diabetes, Lipid Disturbances, Hypertension, and Hyperuricemia among Subjects in the SOS Study over 2- and 10-Year Periods

Lars Sjöström et al N Engl J Med 2004; 351: Incidence of Diabetes, Lipid Disturbances, Hypertension, and Hyperuricemia among Subjects in the SOS Study over 2- and 10-Year Periods

Lars Sjöström et al N Engl J Med 2004; 351: Recovery from Diabetes, Lipid Disturbances, Hypertension, and Hyperuricemia over 2 and 10 Years in Surgically Treated Subjects and Their Obese Controls

Lars Sjöström et al N Engl J Med 2004; 351: Recovery from Diabetes, Lipid Disturbances, Hypertension, and Hyperuricemia over 2 and 10 Years in Surgically Treated Subjects and Their Obese Controls